Physician

Anita Lopes Repp, MD

According to 2025 Medicare claims, Anita Repp, MD (NPI: 1396967022) practices endocrinology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is ANN ARBOR ENDOCRINOLOGY AND DIABETES ASSOCIATES, P.C. (NPI: 1750445961; TIN: 382994459) and primary practice location at 48197-1014. Repp is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588), participating under the MSSP model.

Repp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 843 HCPCS/CPT codes, and received $66,441 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,346 prescription claims across 480 beneficiaries totaling $1,692,980 in drug costs, led by Ozempic (Semaglutide). DME data shows 434 claims. Open Payments data shows 12 records totaling $6,111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $50,296 to $66,441. Similarly, Part D prescription costs have risen steadily, from $772,373 to $1,692,980. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $16,177 to $125,357.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	292	641	$50,296
2016	296	664	$47,658
2017	323	597	$50,854
2018	293	530	$45,526
2019	353	660	$56,301
2020	276	553	$42,042
2021	305	620	$54,429
2022	378	749	$65,454
2023	393	864	$71,809
2024	337	843	$66,441

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	261	2,195	$772,373
2016	285	2,562	$959,050
2017	298	2,606	$1,062,030
2018	316	2,769	$1,211,883
2019	338	2,927	$1,364,520
2020	345	3,143	$1,432,756
2021	354	3,185	$1,608,650
2022	451	3,317	$1,895,992
2023	448	3,243	$2,006,192
2024	480	3,346	$1,692,980

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	195	532	$25,346
2016	196	512	$17,640
2017	181	431	$20,298
2018	192	554	$56,735
2019	161	693	$92,658
2020	140	607	$102,891
2021	112	568	$101,909
2022	113	540	$94,204
2023	134	628	$125,227
2024	107	434	$133,855

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	37	40	$133
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	46	46	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	295	503	$90
76536	Ultrasound scan of head and neck soft tissue	44	47	$84
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	68	186	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	220	12,992	$404,321
Jardiance	Empagliflozin	222	17,160	$315,186
Mounjaro	Tirzepatide	90	5,054	$175,252
Trulicity	Dulaglutide	57	3,276	$106,927
Farxiga	Dapagliflozin Propanediol	54	3,360	$59,240

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	49	230	$95,036
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	34	$12,888
E0784	External ambulatory infusion pump, insulin	Y	N/R	36	$11,389
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	12	33	$8,080
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	13	13	$2,706

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$4,333	Ascendis Pharma Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$1,778	Ascendis Pharma Inc
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anita Lopes Repp, MD?

Tedicare shows public-source Medicare data for Anita Lopes Repp, MD (NPI 1396967022), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita Lopes Repp, MD have ACO affiliation data?

Anita Lopes Repp, MD is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588).

What billing organization is linked to Anita Lopes Repp, MD?

Anita Lopes Repp, MD is linked to ANN ARBOR ENDOCRINOLOGY AND DIABETES ASSOCIATES, P.C. (billing NPI 1750445961) in the available physician profile data.

Does Anita Lopes Repp, MD have Open Payments data?

Anita Lopes Repp, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.